Bids Are Invited For Price Registration For Future Request For Injectable Onco/Hemato Grade 1 To Supply The Pharmacy Division Of The Federal Hospital Of Bonsucesso (33374.038337/202133). Hfl, Hfi, Hupes And Hfse Must Express Interest Using The Quantities Present In The Spreadsheet Attached To This Irp. It Is Worth Noting That Two Items Were Removed From The Irp (Carmustine, 100, Injectable Use And Calcium Folinate, 3 Mg/Ml, Injectable Solution) Due To The Failure Of Marketing Research.

Price Registration For Future Request For Injectable Onco/Hemato Grade 1 To Supply The Pharmacy Division Of The Federal Hospital Of Bonsucesso (33374.038337/202133). Hfl, Hfi, Hupes And Hfse Must Express Interest Using The Quantities Present In The Spreadsheet Attached To This Irp. It Is Worth Noting That Two Items Were Removed From The Irp (Carmustine, 100, Injectable Use And Calcium Folinate, 3 Mg/Ml, Injectable Solution) Due To The Failure Of Marketing Research.. Zoledronic Acid, Azacitidine, Bleomycin Sulfate, Bortezomib, Cetuximab, Cladribine, Dacarbazine, Daunorubicin, Epirubicin Hydrochloride, Etoposide, Filgrastim, Filgrastim, Fludarabine Phosphate, Calcium Folinate, Fulvestrant, Ganciclovir Sodium, Goserelin Acetate, Irinotecan Chlor Hydrate,Leuprorelin Acetate,Mesna, Mitomycin,Mitoxantrone Hydrochloride,Octreotide,Octreotide,Ondansetron Hydrochloride,Ondansetron Hydrochloride,Sodium Pamidronate,Panitumomab,Topotecan Hydrochloride,Trastuzumab,Vimblastine,Vincristine,Ondansetron Hydrochloride